Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
By H. Kirii, T. Niwa, Yasuhiro Yamada, H. Wada, Kuniaki Saito, Y. Iwakura, M. Asano, H. Moriwaki, M. Seishima. Arteriosclerosis, Thrombosis and Vascular Biology, 2003
616 citations recorded by the source corpus.
Objective—Atherosclerosis is considered to be a chronic inflammatory disease and many cytokines participate in the development of atherosclerosis. We focused on the role of interleukin-1&bgr; (IL-1&bgr;), one of the proinflammatory cytokines secreted by monocytes/macrophages, in the progression of atherosclerosis. Methods and Results—We generated mice lacking both apoE and IL-1&bgr;. The sizes of atherosclerotic lesions at the aortic sinus in apoE−/−/IL-1&bgr;−/−mice at 12 and 24 weeks of age showed a significant decrease of approximately 30% compared with apoE−/−/IL-1&bgr;+/+ mice, and the percentage of the atherosclerotic area to total area of apoE−/−/IL-1&bgr;−/− at 24 weeks of age also showed a significant decrease of about 30% compared with apoE−/−/IL-1&bgr;+/+. The mRNA levels of vascular cell adhesion molecule (VCAM)-1 and monocyte chemotactic protein-1 in the apoE−/−/IL-1&bgr;−/− aorta were significantly reduced compared with the apoE−/−/IL-1&bgr;+/+. Furthermore, VCAM-1 was also reduced at the protein level in apoE−/−/IL-1&bgr;−/− aorta compared with apoE−/−/IL-1&bgr;+/+. Conclusions—The lack of IL-1&bgr; decreases the severity of atherosclerosis in apoE deficient mice, possibly through increased expressions of VCAM-1 and monocyte chemotactic protein-1 in the aorta.
Subfields: Epidemiology, Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/830c97c506e4344577d9d78596c31d80d2591b86
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Immunology
In Molecular Biology
Citations in the corpus
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer (2009, background): “, and targeted inhibition of this cytokine reduces markers of diseas”
- Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways (2004, background): “Recent studies in mice lacking expression of either IL-1β or IL-18 provide evidence for their involvement in atherogenesi”